Captor Therapeutics Spolka Akcyjna (CTX.WA)
PLN 47.8
(5.99%)
PLN 47.8
(5.99%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 13.2 Million | 9.15 Million | 3.98 Million | - | - | 16 Thousand |
| Cost of Revenue | 6.3 Million | 2.08 Million | 741 Thousand | 6.6 Million | 4.45 Million | 2.58 Million |
| Gross Profit | 6.9 Million | 7.07 Million | 3.24 Million | -6.6 Million | -4.45 Million | -2.57 Million |
| Operating Expenses | 79.91 Million | 45.43 Million | 34.95 Million | 12.21 Million | 7.85 Million | 4.14 Million |
| Selling, General and Administrative Expenses | 22.17 Million | 19.55 Million | 19.54 Million | 4.2 Million | 2.44 Million | 1.1 Million |
| Research and Development Expenses | 64.84 Million | 44.15 Million | 23.11 Million | 23.57 Million | 19.21 Million | 10.65 Million |
| Other Expenses | -7.1 Million | -18.27 Million | -7.7 Million | -15.55 Million | -13.8 Million | -7.6 Million |
| Cost and Expenses | 86.21 Million | 47.52 Million | 35.69 Million | 12.21 Million | 7.85 Million | 4.14 Million |
| Operating Income | -73.01 Million | -38.36 Million | -31.7 Million | -12.21 Million | -7.85 Million | -4.13 Million |
| Interest Expense | 323 Thousand | 321 Thousand | 400 Thousand | 393 Thousand | 430 Thousand | 266 Thousand |
| Income Tax Expense | 57 Thousand | -2.47 Million | 400 Thousand | 393 Thousand | 430 Thousand | -26 Thousand |
| Earnings before Tax | -70.52 Million | -35.89 Million | -32.57 Million | -12.69 Million | -8.3 Million | -4.42 Million |
| Net Income | -70.58 Million | -33.42 Million | -32.97 Million | -13.08 Million | -8.73 Million | -4.42 Million |
| Earnings Per Share Basic | -15.19 | -8.02 | -7.99 | -4.02 | -2.68 | -1.36 |
| Earnings Per Share Diluted | -15.19 | -8.02 | -7.99 | -4.02 | -2.68 | -1.36 |
| Weighted Average Shares Outstanding | 4.64 Million | 4.16 Million | 4.12 Million | 3.25 Million | 3.25 Million | 3.25 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.64 Million | 4.16 Million | 4.12 Million | 3.25 Million | 3.25 Million | 3.25 Million |
| Gross Margin | 0.52 | 0.77 | 0.81 | - | - | -160.62 |
| EBIT Margin | -4.91 | -3.11 | -6.23 | - | - | -98.12 |
| Profit Margin | -5.35 | -3.65 | -8.27 | - | - | -276.38 |
| EBITDA | -64.76 Million | -28.22 Million | -24.41 Million | -5.61 Million | -3.41 Million | -1.57 Million |
| Earnings Before Tax Margin | -5.53 | -4.19 | -7.95 | - | - | -258.12 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 4.83 Million | 4.5 Million | 6.48 Million | 13.2 Million | 2.81 Million | 2.35 Million |
| Cost of Revenue | 2.49 Million | 1.52 Million | 4.99 Million | 11.27 Million | 1.76 Million | -162 Thousand |
| Gross Profit | 2.33 Million | 2.98 Million | 1.49 Million | 1.92 Million | 1.05 Million | 2.52 Million |
| Operating Expenses | 13.08 Million | 12.7 Million | 18.13 Million | 82.04 Million | 17.32 Million | 32.24 Million |
| Selling, General and Administrative Expenses | 4.7 Million | 2.6 Million | 4.03 Million | - | 5.09 Million | 4.09 Million |
| Research and Development Expenses | 8.38 Million | 10 Million | 14.09 Million | - | 15.38 Million | 21.44 Million |
| Other Expenses | -628 Thousand | - | - | - | - | - |
| Cost and Expenses | 15.58 Million | 14.22 Million | 23.12 Million | 93.32 Million | 19.08 Million | 32.08 Million |
| Operating Income | -10.75 Million | -9.72 Million | -16.63 Million | -80.12 Million | -16.26 Million | -29.72 Million |
| Interest Expense | 81 Thousand | 59 Thousand | 75 Thousand | 269 Thousand | 65 Thousand | 65 Thousand |
| Income Tax Expense | - | 341 Thousand | 1.09 Million | 57 Thousand | 557 Thousand | 57 Thousand |
| Earnings before Tax | -9.98 Million | -9.44 Million | -11.48 Million | -70.52 Million | -15.77 Million | -29.03 Million |
| Net Income | -9.98 Million | -9.44 Million | -11.48 Million | -70.58 Million | -15.77 Million | -29.09 Million |
| Earnings Per Share Basic | -2.14 | -2.04 | -2.47 | - | -3.72 | -6.91 |
| Earnings Per Share Diluted | -2.14 | -2.04 | -2.47 | - | -3.72 | -6.91 |
| Weighted Average Shares Outstanding | 4.66 Million | 4.62 Million | 4.64 Million | 4.64 Million | 4.24 Million | 4.2 Million |
| Weighted Average Shares Outstanding (Diluted) | 4.66 Million | 4.62 Million | 4.64 Million | 4.64 Million | 4.24 Million | 4.2 Million |
| Gross Margin | 0.48 | 0.66 | 0.23 | 0.15 | 0.37 | 1.07 |
| EBIT Margin | -1.95 | -1.83 | -2.39 | - | -5.15 | -11.66 |
| Profit Margin | -2.06 | -2.10 | -1.77 | -5.35 | -5.61 | -12.33 |
| EBITDA | -9.4 Million | -8.26 Million | -15.5 Million | - | -14.49 Million | -27.49 Million |
| Earnings Before Tax Margin | -2.22 | -2.16 | -2.57 | -6.07 | -5.78 | -12.60 |
LKPSEC
002712
SWASTIKA
HOWARHO
MARIS
PRPM